EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Evolving Role of Eosinophils in Eosinophilic Esophagitis: Mechanisms, Crosstalk, and Therapeutic Perspectives

Federico Caldart iD, Luisa Bertin iD, Annalisa Tortora iD, Alberto Barchi iD, Niccolò Seregni, Pierfrancesco Visaggi iD, Nicola De Bortoli iD, Marco Caminati iD, Marco Zurlo iD, Luca Frulloni iD, Edoardo Vincenzo Savarino iD

Cells · 01.07.2026 · 15 (13) · 1200

DOI: 10.3390/cells15131200 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 01.07.2026. Verfasst von Federico Caldart und 10 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Unit, Department of Medicine, Verona University Hospital, Piazzale L.A. Scuro 9, 37134 Verona, Italy. Hauptthemen laut MEDLINE: Eosinophilic Esophagitis, Eosinophils. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Eosinophilic esophagitis (EoE) is a chronic immune-mediated esophageal disease characterized by eosinophilic infiltration, epithelial barrier dysfunction, and progressive tissue remodeling. Increasing evidence identifies eosinophils as central drivers of inflammation and fibrosis, linking EoE to type 2 immune responses and allergic disorders. However, the molecular mechanisms underlying eosinophil-mediated esophageal damage and their interaction with gastroesophageal reflux disease (GERD) remain incompletely understood. Material and Methods: A comprehensive narrative review of the current literature was conducted, focusing on studies investigating eosinophil biology, inflammatory signaling pathways, epithelial remodeling, fibrosis, and therapeutic targets in EoE. Clinical, translational, and experimental studies evaluating the association between EoE, GERD, and allergic comorbidities were critically analyzed.

Results

Available evidence demonstrates that eosinophils actively contribute to EoE pathogenesis through the release of cytotoxic granule proteins, cytokines, chemokines, and lipid mediators, leading to chronic inflammation and fibrostenotic remodeling. Dysregulation of type 2 cytokines, particularly IL-4, IL-5, and IL-13, plays a pivotal role in disease progression and immune cell recruitment. Significant overlap between EoE and GERD suggests shared inflammatory mechanisms and diagnostic challenges. Furthermore, EoE frequently coexists with systemic allergic diseases, supporting the concept of a broader atopic inflammatory phenotype. Emerging biologic therapies targeting eosinophilic and type 2 inflammatory pathways have shown promising efficacy in reducing symptoms and histologic activity.

Conclusions

Eosinophils represent key regulators of EoE pathobiology and constitute promising biomarkers and therapeutic targets. A deeper understanding of eosinophil-driven inflammatory networks may improve diagnostic accuracy, patient stratification, and the development of personalized therapeutic strategies for EoE and related esophageal inflammatory disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eosinophilic EsophagitisEosinophilsHumansAnimalsCytokinesSignal TransductionGastroesophageal RefluxInflammation

Stichwörter der Autor:innen

GERDeosinophilic esophagitiseosinophils

Substanzen

Cytokines

Autor:innen und Institutionen

  • Gastroenterology Unit, Department of Medicine, Verona University Hospital, Piazzale L.A. Scuro 9, 37134 Verona, Italy.
  • Department of Surgery, Oncology and Gastroenterology, University of Padua, Via Giustiniani 2, 35128 Padua, Italy.
  • Gastroenterology Unit, Azienda Ospedale Università of Padua, Via Giustiniani 2, 35128 Padua, Italy.
  • Division of Gastroenterology and Gastrointestinal Endoscopy, IRCCS Ospedale San Raffaele, Via Olgettina 58, 20132 Milan, Italy.
  • Faculty of Medicine, Università Vita-Salute San Raffaele, Via Olgettina 58, 20132 Milan, Italy.
  • Gastroenterology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Lungarno Pacinotti 43, 56126 Pisa, Italy.

ORCID-Profile: Federico Caldart, Luisa Bertin, Annalisa Tortora, Alberto Barchi, Pierfrancesco Visaggi, Nicola De Bortoli, Marco Caminati, Marco Zurlo, Luca Frulloni, Edoardo Vincenzo Savarino

Zitieren

APA

Caldart, F., Bertin, L., Tortora, A., Barchi, A., Seregni, N., Visaggi, P., De Bortoli, N., Caminati, M., Zurlo, M., Frulloni, L., & Savarino, E. V. (2026). The Evolving Role of Eosinophils in Eosinophilic Esophagitis: Mechanisms, Crosstalk, and Therapeutic Perspectives. Cells, 15(13), 1200. https://doi.org/10.3390/cells15131200

Vancouver

Caldart F, Bertin L, Tortora A, Barchi A, Seregni N, Visaggi P, et al. The Evolving Role of Eosinophils in Eosinophilic Esophagitis: Mechanisms, Crosstalk, and Therapeutic Perspectives. Cells. 2026;15(13):1200. doi:10.3390/cells15131200

BibTeX
@article{Caldart2026,
  author = {Caldart, Federico and Bertin, Luisa and Tortora, Annalisa and Barchi, Alberto and Seregni, Niccolò and Visaggi, Pierfrancesco and De Bortoli, Nicola and Caminati, Marco and Zurlo, Marco and Frulloni, Luca and Savarino, Edoardo Vincenzo},
  title = {The Evolving Role of Eosinophils in Eosinophilic Esophagitis: Mechanisms, Crosstalk, and Therapeutic Perspectives},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {13},
  pages = {1200},
  doi = {10.3390/cells15131200}
}
Kostenlos starten →